Cyclosporine A inhibits tissue factor expression in monocytes/macrophages

Blood

Volumn 88, Issue 10, 1996, Pages 3837-3845

  Hölschermann, Hans ^a   Dürfeld, Frank ^b   Maus, Ulrich ^b   Bierhaus, Angelika ^b   Heidinger, Kathrin ^b   Lohmeyer, Jürgen ^b   Nawroth, Peter P ^b   Tillmanns, Harald ^b   Haberbosch, Werner ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROCOAGULANT; THROMBOPLASTIN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; CORONARY ARTERY ATHEROSCLEROSIS; DOSE RESPONSE; FIBRIN DEPOSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL TIME; TRANSCRIPTION REGULATION;

EID: 0029844707     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3837.bloodjournal88103837     Document Type: Article

References (47)

1. Billingham ME: Histopathology of graft coronary disease. J Heart Lung Transplant 11:S38, 1992
2. Hosenpud JD, Shipley GD, Wagner CR: Cardiac allograft vasculopathy: Current concepts, recent developments, and future directions. J Heart Lung Transplant 11:9, 1992
3. Schroeder JS, Gao SZ, Hunt SA, Stinson EB: Accelerated graft coronary artery disease: Diagnosis and prevention. J Heart Lung Transplant 11:5258, 1992
4. Uretsky BF, Kormos RL, Zerbe TR, Lee A, Tokarczyk TR, Murali S, Reddy PS, Denys BG, Griffith BP, Hardesty RL, Armitage JM, Arena VC: Cardiac events after heart transplantation: Incidence and predictive value of coronary arteriography. J Heart Lung Transplant 11:845, 1992
5. Paul LC: Chronic rejection of organ allografts. Magnitude of the problem. Transplant Proc 25:2024, 1993
6. Faulk WP, Labarrere CA: Vascular immunopathology and atheroma development in human allografted organs. Arch Pathol Lab Med 116:1337, 1992
7. Adams DH, Wyner LR, Steinbeck MJ, Karnovsky MJ: Inhibition of graft arteriosclerosis by modulation of the inflammatory response. Transplant Proc 25:2092, 1993
8. Roessner A, Bogeholz J, Bosse A, Vollmer E, Buchholz E, Winde G, Brundermann H: [Immunohistological differentiation of the cells of the arterial wall in transplanted kidneys]. Verh Dtsch Ges Pathol 73:242, 1989
9. Smith EB, Thompson WD: Fibrin as a factor in atherogenesis. Thromb Res 73:1, 1994
10. Rivers RP, Hathaway WE, Weston WL: The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30:311, 1975
11. Solis E, Kaye MP: The Registry of the International Society for Heart Transplantation: Third official report - June 1986. J Heart Transplant 5:2, 1986
12. Zusman DR, Stinson EB, Oyer PE, Baldwin JC, Jamieson SW, McGregor CG, Hunt S: Determinants of accelerated graft atherosclerosis (AGAS) in conventional and cyclosporine treated heart transplant recipients. J Heart Transplant 4:587, 1985 (abstr)
13. Hess ML, Hastillo A, Thompson JA, Sansonetti DJ, Szentpetery S, Barnhart G, Lower RR: Lipid mediators in organ transplantation: Does cyclosporine accelerate coronary atherosclerosis? Transplant Proc 19:71, 1987
14. Anderson HO, Madsen G, Nordestgaard BG, Kjeldsen K, Stender S: Cyclosporine suppresses experimental transplant atherosclerosis. Transplant Proc 26:1738, 1994
15. Andersen HO, Madsen G, Nordestgaard BG, Hansen BF, Kjeldsen K, Stender S: Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability. Arterioscler Thromb 14:944, 1994
16. Jonasson L, Holm J, Hansson GK: Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci USA 85:2303, 1988
17. Boyum A: Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at lg. Scand J Clin Lab Invest 21:77, 1963 (suppl 97)
18. Helin H, Edgington TS: Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med 158:962, 1983
19. Giles KW, Myers A: An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 206:93, 1965
20. Schreiber E, Mattias P, Müller MM, Schaffner W: Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
21. Chomczynski P, Sacchi N: Single step method of RNA-isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
22. Scarpati EM, Wen D, Broze G, Miletich JP, Flandermayer RR, Siegel NR, Sadler E: Human tissue factor: cDNA-sequence and chromosome localization of the gene. Biochemistry 26:5234, 1987
23. Pahl HL, Baeuerle PA: Expression of influenza virus hemagglutinin activates transcription factor NFkB. J Virol 69:1480, 1995
24. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Bohrer H, Greten J, Eike M, Bauerle P, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP: Mechanism of the TNFα mediated induction of endothelial tissue factor, J Biol Chem 270:26419, 1995
25. Parry GC, Mackman N: A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 269:20823, 1994
26. Mackman N: Regulation of the tissue factor gene. FASEB J 9:883, 1995
27. Moll T, Czyz M, Holzmüller H, Hofer-Warbinek R, Wagner E, Winkler H, Bach FH, Hofer E: Regulation of the tissue factor promotor in endothelial cells. J Biol Cell 270:3849, 1995
28. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, Mackman N: Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol 14:3772, 1994
29. Fahr A: Cyclosporin clinical pharmacokinetics. Clin Pharmcokinet 24:472, 1993
30. Carlsen E, Gaudernack G, Filion-Myklebust C, Pettersen KS, Prydz H: Allogeneic induction of thromboplastin synthesis in monocytes and endothelial cells. Biphasic effect of cyclosporin A. Clin Exp Immunol 76:428, 1989
31. Carlsen E, Flatmark A, Prydz H: Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. Transplantation 46:575, 1988
32. Carlsen E, Stinessen MB, Prydz H: Differential effect of α-interferon and γ-interferon on thrombplastin response in monocytes and endothelial cells. Clin Exp Immunol 70:471, 1987
33. Carlsen E, Prydz H: Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine. Transplantation 43:543, 1987
34. Ferreira OC Jr, Barcinski MA: Autologous induction of the human T-cell-dependent monocyte procoagulant activity: A possible link between immunoregulatory phenomena and blood coagulation. Cell Immunol 101:259, 1986
35. Helin HJ, Edgington TS: Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: Inhibition of monocyte procoagulant response to allogeneic stimulation. J Immunol 132:1074, 1984
36. Schwartz BS, Levy GA, Edgington TS: Immune complex-induced human monocyte procoagulant activity. II. Cellular kinetics and metabolic requirements. J Immunol 128:1037, 1982
37. Lyberg T, Prydz H, Baklien K, Hoyeraal HM: Effect of immune complex-containing sera from patients with rheumatic diseases on thromboplastin activity of monocytes. Thromb Res 25:193, 1982
38. Kucey DS, Cheung PY, Marshall JC, Rotstein OD: Modulation of macrophage procoagulant activity by arachidonic acid metabolites. J Surg Res 52:549, 1992
39. Gregory SA, Morrissey JH, Edgington TS: Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9:2752, 1989
40. Mészâros K, Aberle S, Dedrick R, Machovich R, Horwitz A, Birr C, Theofan G, Parent JB: Monocyte tissue factor induction by lipopolysaccharide (LPS): Dependence on LPS-binding protein and CD 14, and inhibition by a recombinant fragment of bacterial/permeability-increasing protein. Blood 83:2516, 1994
41. Steinemann S, Ulevitch RJ, Mackman N: Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb 14:1202, 1994
42. Müller JM, Ziegler-Heitbrock HWL, Baeuerle PA: Nuclear factor kappa B, a mediator of polysaccharide effects. Immunobiology 187:233, 1993
43. Mackman N, Brand K, Edgington TS: Lipopolysaccharidemediated transcriptional activation of the human tissue factor gene in THP-I monocytic cells requires both activator protein I and nuclear factor kappa B binding sites. J Exp Med 174:1517, 1991
44. Baeuerle PA, Baltimore D: I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science 242:540, 1988
45. Baeuerle PA, Baltimore D: Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53:211, 1988
46. Ghosh S, Baltimore D: Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 344:678, 1990
47. Sen R, Baltimore D: Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell 47:921, 1986